Suppr超能文献

由CLCN5基因新型内含子突变引起的伴有 Dent 病的严重骨软化症

Severe Osteomalacia with Dent Disease Caused by a Novel Intronic Mutation of the CLCN5 gene.

作者信息

Matsumoto Ayumi, Matsui Isao, Mori Takayasu, Sakaguchi Yusuke, Mizui Masayuki, Ueda Yoshiyasu, Takahashi Atsushi, Doi Yohei, Shimada Karin, Yamaguchi Satoshi, Kubota Keiichi, Hashimoto Nobuhiro, Oka Tatsufumi, Takabatake Yoshitsugu, Sohara Eisei, Hamano Takayuki, Uchida Shinichi, Isaka Yoshitaka

机构信息

Department of Nephrology, Osaka University Graduate School of Medicine, Japan.

Department of Nephrology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Japan.

出版信息

Intern Med. 2018 Dec 15;57(24):3603-3610. doi: 10.2169/internalmedicine.1272-18. Epub 2018 Aug 10.

Abstract

We present a case of Dent disease caused by a novel intronic mutation, 1348-1G>A, of the chloride voltage-gated channel 5 (CLCN5) gene. Cultured proximal tubule cells obtained from the patient showed impaired acidification of the endosome and/or lysosome, indicating that the 1348-1G>A mutation was indeed the cause of Dent disease. Although the prevalence of osteomalacia in Dent disease is low in Japan, several factors-including poor medication adherence-caused severe osteomalacia in the current case. Oral supplementation with calcium and native/active vitamin D therapy, with careful attention to medication adherence, led to the improvement of the patient's bone status.

摘要

我们报告了一例由氯离子电压门控通道5(CLCN5)基因的新型内含子突变1348-1G>A引起的丹特病病例。从患者身上获取的培养近端小管细胞显示内体和/或溶酶体酸化受损,表明1348-1G>A突变确实是丹特病的病因。尽管在日本丹特病中骨软化症的患病率较低,但在当前病例中,包括药物依从性差在内的几个因素导致了严重的骨软化症。口服补充钙和天然/活性维生素D治疗,并密切关注药物依从性,使患者的骨骼状况得到改善。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e440/6355425/514cb8f6a2c2/1349-7235-57-3603-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验